15 pt?
Jefferies Initiates Coverage On Tempest Therapeutics With Buy Rating, Announces Price Target of $15
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
